A novel mouse model identifies cooperating mutations and therapeutic targets critical for chronic myeloid leukemia progression. (2015)
Attributed to:
Characterising and targeting aberrant enhancer function in acute myeloid leukaemia (AML)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1084/jem.20141661
PubMed Identifier: 26304963
Publication URI: http://europepmc.org/abstract/MED/26304963
Type: Journal Article/Review
Volume: 212
Parent Publication: The Journal of experimental medicine
Issue: 10
ISSN: 0022-1007